HIV infection and Cardiovascular Disease - Is There Really a Link?

New England Journal of Medicine

Volumn 349, Issue 21, 2003, Pages 2065-2067

  Sklar, Peter ^a   Masur, Henry ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHOLESTEROL; INDINAVIR; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; DATA BASE; EDITORIAL; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; METABOLIC DISORDER; MORTALITY; PRIORITY JOURNAL; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTI-RETROVIRAL AGENTS; CARDIOVASCULAR DISEASES; HIV INFECTIONS; HUMANS; HYPERLIPIDEMIAS; MYOCARDIAL INFARCTION;

EID: 0345357772     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe038158     Document Type: Editorial

References (11)

1. Mary-Krause MCL, Partisani M, Simon A, Costagliola D. Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV infected men. Presented at the Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001. abstract.
2. Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002;360:1747-8.
3. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003;33:506-12.
4. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30:471-7.
5. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10.
6. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
7. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59:91G-94G. [Erratum, Am J Cardiol 1987;60:All.]
8. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59:91G-94G. [Erratum, Am J Cardiol 1987;60:A11.]
9. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003;289:2978-82.
10. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 1993;76:1423-7.
11. Dube MP SS, Vanderluitgaren JM, Leffler CM, Baron AD, Steinberg HO. Effect of indinavir (IND) monotherapy on endothelial function in men without HIV infection. Presented at the Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, February 24-28, 2002. abstract.